Disease Info Card

Atrial Fibrillation

Information about Atrial Fibrillation: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Atrial Fibrillation

Most recent studies have shown that Atrial Fibrillation shares some biological mechanisms with atrial-flutter, cardiac-arrhythmia, cardiac-fibrillation, cardiomyopathies, cerebrovascular-accident, chronic-atrial-fibrillation, coronary-heart-disease, diabetes-mellitus, embolism, heart-diseases, heart-failure, hemorrhage, hypertensive-disease, infarction, myocardial-infarction, paroxysmal-atrial-fibrillation, stenosis, tachycardia-ventricular, thromboembolism, thrombosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Atrial Fibrillation, and have been seen in publications frequently: Aging, Cardiac Conduction, Coagulation, Dehiscence, Excretion, Fibrinolysis, Glomerular Filtration, Hemostasis, Hypersensitivity, Inflammatory Response, Innervation, Localization, Pathogenesis, Platelet Activation, Platelet Aggregation, Reflex, Secretion, Segmentation, Transport, Transposition

Quite a number of genes have been found to play important roles in Atrial Fibrillation, such as ACE, AGT, CALR, CFH, CRP, CS, DCX, F10, F2, GNL3, GZMA, KRAS, KRT5, NPPB, PSMD4, SCTR, SNCG. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.